Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative NeoplasmsAndrew Dunbar, Ross L. Levine, Robert L. Bowman et al.|Cancer Discovery|2024Cited by 30
Transcription factor induction of vascular blood stem cell niches in vivoElliott J. Hagedorn, Leonard I. Zon, Julie R. Perlin et al.|Developmental Cell|2023Cited by 20
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancyRobert L. Bowman, Ross L. Levine, Andrew Dunbar et al.|Cancer Cell|2024Cited by 12
<i>Jak2V617F</i> Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)Andrew Dunbar, Ross L. Levine, Max Brodsky et al.|Blood|2022Cited by 4
Jak2 <sup>V617F</sup> Reversible Activation Shows an Essential Requirement for Jak2 <sup>V617F</sup> in Myeloproliferative NeoplasmsAndrew Dunbar, Ross L. Levine, Robert L. Bowman et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2